10/31/2007

The FDA has granted Barr Laboratories tentative approval to market a generic version of Mirapex tablets for the treatment of Parkinson's disease. Barr's version of the drug by Boehringer Ingelheim Pharmaceuticals comes in tablet strengths of 0.125 mg to 1.5 mg.

Full Story:
Forbes

Related Summaries